Lataa...

Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.

This study describes the effects of bezafibrate, an analogue of clofibrate, on the plasma lipid and lipoprotein profiles of 11 hypertriglyceridemic subjects and on their metabolism of apolipoproteins A-I, A-II, and B. The major action of the drug was to lower plasma triglyceride (by 58%; P less than...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Invest
Päätekijät: Shepherd, J, Packard, C J, Stewart, J M, Atmeh, R F, Clark, R S, Boag, D E, Carr, K, Lorimer, A R, Ballantyne, D, Morgan, H G
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Clinical Investigation 1984
Aiheet:
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC425409/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6511921/
https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI111643
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!